Original Research
Published on 06 Sep 2023
Impact of the TLR4 agonist BECC438 on a novel vaccine formulation against Shigella spp.
in Vaccines and Molecular Therapeutics
- 3,165 views
- 5 citations
Original Research
Published on 06 Sep 2023
in Vaccines and Molecular Therapeutics
Original Research
Published on 06 Sep 2023
in Vaccines and Molecular Therapeutics
Review
Published on 05 Sep 2023
in Vaccines and Molecular Therapeutics
Original Research
Published on 01 Sep 2023
in Vaccines and Molecular Therapeutics
Original Research
Published on 01 Sep 2023
in Vaccines and Molecular Therapeutics
Original Research
Published on 01 Sep 2023
in Vaccines and Molecular Therapeutics
Mini Review
Published on 01 Sep 2023
in Vaccines and Molecular Therapeutics
Original Research
Published on 01 Sep 2023
in Vaccines and Molecular Therapeutics
Original Research
Published on 31 Aug 2023
in Vaccines and Molecular Therapeutics
Original Research
Published on 29 Aug 2023
in Vaccines and Molecular Therapeutics
Original Research
Published on 25 Aug 2023
in Vaccines and Molecular Therapeutics
Original Research
Published on 25 Aug 2023
in Vaccines and Molecular Therapeutics
Original Research
Published on 23 Aug 2023
in Vaccines and Molecular Therapeutics
Original Research
Published on 22 Aug 2023
in Vaccines and Molecular Therapeutics
Original Research
Published on 18 Aug 2023
in Vaccines and Molecular Therapeutics
Editorial
Published on 18 Aug 2023
in Vaccines and Molecular Therapeutics